14159 capital (GP), LLC Insider Trading Transactions
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is Director in INCYTE CORP ($INCY) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Latest Insider Trading Transactions of 14159 capital (GP), LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, IBPI, AUXL, GHDX, INCY, TZYM, PCYC, SGEN, GEVA, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 3.01 | 910 | 2,735 | 57,704 | 56.8 K to 57.7 K (+1.60 %) |
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.99 | 1,482 | 4,430 | 56,794 | 55.3 K to 56.8 K (+2.68 %) |
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.96 | 4,186 | 12,383 | 55,312 | 51.1 K to 55.3 K (+8.19 %) |
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.55 | 15,076 | 38,444 | 51,126 | 36.1 K to 51.1 K (+41.82 %) |
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 2.34 | 8,628 | 20,186 | 36,050 | 27.4 K to 36.1 K (+31.46 %) |
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.87 | 1,170 | 2,188 | 27,422 | 26.3 K to 27.4 K (+4.46 %) |
Mar 14 2012 | TZYM | Ocera Therapeutics ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 1.89 | 430 | 811 | 26,252 | 25.8 K to 26.3 K (+1.67 %) |
Jan 09 2012 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 25.18 | 29,089 | 732,461 | 135,739 | 106.7 K to 135.7 K (+27.28 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.89 | 1,944 | 34,784 | 195,858 | 193.9 K to 195.9 K (+1.00 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.95 | 4,360 | 78,265 | 193,914 | 189.6 K to 193.9 K (+2.30 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.43 | 454 | 8,368 | 189,554 | 189.1 K to 189.6 K (+0.24 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.55 | 2,792 | 51,784 | 189,100 | 186.3 K to 189.1 K (+1.50 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.01 | 2,202 | 39,651 | 186,308 | 184.1 K to 186.3 K (+1.20 %) |
Jan 26 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.86 | 1,193 | 21,303 | 184,106 | 182.9 K to 184.1 K (+0.65 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Option Exercise | X | 15.00 | 2 | 30 | 0 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Option Exercise | X | 15.00 | 5 | 75 | 2 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Option Exercise | P | 15.00 | 2 | 30 | 7 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Option Exercise | P | 15.00 | 5 | 75 | 5 | |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.84 | 1,201 | 20,225 | 182,913 | 181.7 K to 182.9 K (+0.66 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.88 | 1,923 | 32,457 | 181,712 | 179.8 K to 181.7 K (+1.07 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.90 | 1,149 | 19,415 | 179,789 | 178.6 K to 179.8 K (+0.64 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | X | 15.00 | 200 | 3,000 | 178,640 | 178.4 K to 178.6 K (+0.11 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | X | 15.00 | 500 | 7,500 | 178,440 | 177.9 K to 178.4 K (+0.28 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.44 | 1,824 | 29,984 | 177,940 | 176.1 K to 177.9 K (+1.04 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.41 | 4,712 | 77,322 | 176,116 | 171.4 K to 176.1 K (+2.75 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 15.81 | 66 | 1,043 | 171,404 | 171.3 K to 171.4 K (+0.04 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.07 | 278 | 4,467 | 171,338 | 171.1 K to 171.3 K (+0.16 %) |
Jan 23 2012 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.07 | 594 | 9,545 | 171,060 | 170.5 K to 171.1 K (+0.35 %) |
Jan 17 2012 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 16.62 | 1,122 | 18,648 | 355,839 | 354.7 K to 355.8 K (+0.32 %) |
Jan 17 2012 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 16.58 | 1,965 | 32,576 | 354,717 | 352.8 K to 354.7 K (+0.56 %) |
Jan 17 2012 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 16.46 | 2,769 | 45,570 | 352,752 | 350 K to 352.8 K (+0.79 %) |
Jan 17 2012 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 16.21 | 5,919 | 95,924 | 349,983 | 344.1 K to 350 K (+1.72 %) |
Jan 17 2012 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 16.38 | 2,850 | 46,691 | 344,064 | 341.2 K to 344.1 K (+0.84 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 30.36 | 516 | 15,668 | 227,840 | 227.3 K to 227.8 K (+0.23 %) |
Mar 09 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.88 | 583 | 17,420 | 227,324 | 226.7 K to 227.3 K (+0.26 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 30.07 | 1,845 | 55,477 | 226,741 | 224.9 K to 226.7 K (+0.82 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.96 | 2,254 | 67,521 | 224,896 | 222.6 K to 224.9 K (+1.01 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.52 | 2,419 | 71,410 | 222,642 | 220.2 K to 222.6 K (+1.10 %) |
Mar 05 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.47 | 405 | 11,936 | 220,223 | 219.8 K to 220.2 K (+0.18 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.06 | 4,149 | 120,562 | 219,818 | 215.7 K to 219.8 K (+1.92 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.11 | 1,353 | 39,384 | 215,669 | 214.3 K to 215.7 K (+0.63 %) |
Feb 29 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.03 | 974 | 28,276 | 214,316 | 213.3 K to 214.3 K (+0.46 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.12 | 1,639 | 46,095 | 213,342 | 211.7 K to 213.3 K (+0.77 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.98 | 145 | 4,057 | 211,703 | 211.6 K to 211.7 K (+0.07 %) |
Feb 23 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.98 | 1,238 | 34,635 | 211,558 | 210.3 K to 211.6 K (+0.59 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.85 | 2,419 | 72,219 | 210,320 | 207.9 K to 210.3 K (+1.16 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 29.61 | 2,460 | 72,842 | 207,901 | 205.4 K to 207.9 K (+1.20 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.96 | 10 | 290 | 205,441 | 205.4 K to 205.4 K (0.00 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.88 | 849 | 24,517 | 205,431 | 204.6 K to 205.4 K (+0.41 %) |
Feb 16 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.44 | 1,475 | 41,945 | 204,582 | 203.1 K to 204.6 K (+0.73 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.52 | 753 | 19,967 | 203,107 | 202.4 K to 203.1 K (+0.37 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.62 | 492 | 13,098 | 202,354 | 201.9 K to 202.4 K (+0.24 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.60 | 2,980 | 79,278 | 201,862 | 198.9 K to 201.9 K (+1.50 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.24 | 102 | 2,676 | 198,882 | 198.8 K to 198.9 K (+0.05 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.33 | 1,312 | 34,540 | 198,780 | 197.5 K to 198.8 K (+0.66 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.27 | 64 | 1,681 | 197,468 | 197.4 K to 197.5 K (+0.03 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.26 | 1,594 | 41,851 | 197,404 | 195.8 K to 197.4 K (+0.81 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.18 | 3,585 | 93,840 | 195,810 | 192.2 K to 195.8 K (+1.87 %) |
Feb 10 2012 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.17 | 161 | 4,213 | 192,225 | 192.1 K to 192.2 K (+0.08 %) |
Feb 03 2012 | IBPI | Ardea Biosciences, ... | 14159 capital (GP), LLC | Director | Buy | P | 17.00 | 23,172 | 393,924 | 116,454 | 93.3 K to 116.5 K (+24.84 %) |
Jan 03 2012 | ADLR | ADOLOR CORP | 14159 capital (GP), LLC | 10% Owner | Sell | U | 4.25 | 186,272 | 791,656 | 0 | 186.3 K to 0 (-100.00 %) |
Dec 16 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 27.29 | 7,828 | 213,613 | 303,264 | 295.4 K to 303.3 K (+2.65 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.18 | 6,017 | 109,408 | 295,436 | 289.4 K to 295.4 K (+2.08 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.48 | 1,905 | 33,293 | 289,419 | 287.5 K to 289.4 K (+0.66 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.08 | 3,367 | 60,874 | 287,514 | 284.1 K to 287.5 K (+1.18 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.19 | 1,645 | 29,927 | 284,147 | 282.5 K to 284.1 K (+0.58 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.00 | 6,084 | 109,507 | 282,502 | 276.4 K to 282.5 K (+2.20 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.97 | 3,423 | 61,497 | 276,418 | 273 K to 276.4 K (+1.25 %) |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 0.00 | 90,457 | 0 | 106,650 | 16.2 K to 106.7 K (+558.62 %) |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 0.00 | 8,185 | 0 | 16,193 | 8 K to 16.2 K (+102.21 %) |
Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | 14159 capital (GP), LLC | Director | Grant | A | 0.00 | 7,932 | 0 | 8,008 | 76 to 8 K (+10,436.84 %) |
Dec 06 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 15.42 | 1,895 | 29,227 | 170,466 | 168.6 K to 170.5 K (+1.12 %) |
Dec 06 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 15.39 | 465 | 7,154 | 168,571 | 168.1 K to 168.6 K (+0.28 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 14.26 | 1,815 | 25,879 | 168,106 | 166.3 K to 168.1 K (+1.09 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 14.12 | 2,568 | 36,254 | 166,291 | 163.7 K to 166.3 K (+1.57 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 13.38 | 1,393 | 18,636 | 163,723 | 162.3 K to 163.7 K (+0.86 %) |
Nov 30 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 13.32 | 2,659 | 35,419 | 162,330 | 159.7 K to 162.3 K (+1.67 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.76 | 747 | 9,532 | 159,671 | 158.9 K to 159.7 K (+0.47 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.87 | 2,685 | 34,546 | 158,924 | 156.2 K to 158.9 K (+1.72 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.51 | 807 | 10,094 | 156,239 | 155.4 K to 156.2 K (+0.52 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.01 | 2,143 | 25,746 | 155,432 | 153.3 K to 155.4 K (+1.40 %) |
Nov 23 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 12.25 | 635 | 7,780 | 153,289 | 152.7 K to 153.3 K (+0.42 %) |
Oct 04 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 11.62 | 2,195 | 25,497 | 152,654 | 150.5 K to 152.7 K (+1.46 %) |
Oct 04 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 11.54 | 915 | 10,561 | 150,459 | 149.5 K to 150.5 K (+0.61 %) |
Dec 12 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.26 | 4,789 | 63,499 | 341,214 | 336.4 K to 341.2 K (+1.42 %) |
Dec 12 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.19 | 73 | 963 | 336,425 | 336.4 K to 336.4 K (+0.02 %) |
Dec 12 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.44 | 1,674 | 22,503 | 336,352 | 334.7 K to 336.4 K (+0.50 %) |
Dec 12 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.47 | 4,291 | 57,779 | 334,678 | 330.4 K to 334.7 K (+1.30 %) |
Dec 07 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.22 | 1,845 | 24,399 | 330,387 | 328.5 K to 330.4 K (+0.56 %) |
Dec 07 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.21 | 2,033 | 26,857 | 328,542 | 326.5 K to 328.5 K (+0.62 %) |
Dec 07 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.54 | 3,910 | 52,951 | 326,509 | 322.6 K to 326.5 K (+1.21 %) |
Dec 07 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.52 | 5,147 | 69,575 | 322,599 | 317.5 K to 322.6 K (+1.62 %) |
Dec 07 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.88 | 1,303 | 18,080 | 317,452 | 316.1 K to 317.5 K (+0.41 %) |
Dec 07 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.89 | 27,382 | 380,235 | 316,149 | 288.8 K to 316.1 K (+9.48 %) |
Dec 01 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 13.78 | 7,232 | 99,657 | 288,767 | 281.5 K to 288.8 K (+2.57 %) |
Dec 01 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 14.36 | 8,573 | 123,093 | 281,535 | 273 K to 281.5 K (+3.14 %) |
Dec 01 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 14.18 | 6,575 | 93,208 | 272,962 | 266.4 K to 273 K (+2.47 %) |
Dec 01 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 12.23 | 15,737 | 192,506 | 266,387 | 250.7 K to 266.4 K (+6.28 %) |
Dec 01 2011 | INCY | INCYTE CORP | 14159 capital (GP), LLC | Director | Buy | P | 12.19 | 13,153 | 160,313 | 250,650 | 237.5 K to 250.7 K (+5.54 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.39 | 225 | 6,388 | 192,064 | 191.8 K to 192.1 K (+0.12 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.50 | 323 | 9,205 | 191,839 | 191.5 K to 191.8 K (+0.17 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.06 | 1,965 | 55,131 | 191,516 | 189.6 K to 191.5 K (+1.04 %) |
Dec 05 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 28.03 | 639 | 17,914 | 189,551 | 188.9 K to 189.6 K (+0.34 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.88 | 384 | 9,938 | 188,912 | 188.5 K to 188.9 K (+0.20 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.71 | 155 | 3,985 | 188,528 | 188.4 K to 188.5 K (+0.08 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.03 | 2,044 | 53,206 | 188,373 | 186.3 K to 188.4 K (+1.10 %) |
Nov 23 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.91 | 3,167 | 82,041 | 186,329 | 183.2 K to 186.3 K (+1.73 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.50 | 383 | 10,532 | 183,162 | 182.8 K to 183.2 K (+0.21 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.24 | 568 | 15,474 | 182,779 | 182.2 K to 182.8 K (+0.31 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.90 | 942 | 26,279 | 182,211 | 181.3 K to 182.2 K (+0.52 %) |
Nov 17 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.99 | 657 | 18,387 | 181,269 | 180.6 K to 181.3 K (+0.36 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.25 | 1,567 | 42,707 | 180,612 | 179 K to 180.6 K (+0.88 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.66 | 4,052 | 112,088 | 179,045 | 175 K to 179 K (+2.32 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.89 | 1,509 | 40,573 | 174,993 | 173.5 K to 175 K (+0.87 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.66 | 317 | 8,452 | 173,484 | 173.2 K to 173.5 K (+0.18 %) |
Nov 14 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.80 | 2,661 | 71,326 | 173,167 | 170.5 K to 173.2 K (+1.56 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.20 | 2,538 | 66,503 | 170,506 | 168 K to 170.5 K (+1.51 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.28 | 3,046 | 80,047 | 167,968 | 164.9 K to 168 K (+1.85 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.78 | 2,365 | 60,963 | 164,922 | 162.6 K to 164.9 K (+1.45 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.49 | 857 | 20,985 | 162,557 | 161.7 K to 162.6 K (+0.53 %) |
Nov 07 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.42 | 41 | 1,001 | 161,700 | 161.7 K to 161.7 K (+0.03 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.13 | 1,103 | 19,997 | 272,995 | 271.9 K to 273 K (+0.41 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 18.13 | 5,184 | 93,965 | 271,892 | 266.7 K to 271.9 K (+1.94 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.78 | 2,147 | 38,180 | 266,708 | 264.6 K to 266.7 K (+0.81 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.74 | 6,263 | 111,079 | 264,561 | 258.3 K to 264.6 K (+2.42 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.58 | 523 | 9,197 | 258,298 | 257.8 K to 258.3 K (+0.20 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 17.43 | 2,509 | 43,722 | 257,775 | 255.3 K to 257.8 K (+0.98 %) |
Aug 25 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.97 | 503 | 8,538 | 255,266 | 254.8 K to 255.3 K (+0.20 %) |
Aug 12 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.12 | 1,473 | 23,741 | 254,763 | 253.3 K to 254.8 K (+0.58 %) |
Aug 12 2011 | VPHM | VIROPHARMA INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 16.74 | 4,461 | 74,662 | 253,290 | 248.8 K to 253.3 K (+1.79 %) |
Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 17.27 | 271 | 4,680 | 323,148 | 322.9 K to 323.1 K (+0.08 %) |
Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 17.06 | 1,075 | 18,344 | 322,877 | 321.8 K to 322.9 K (+0.33 %) |
Sep 08 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 17.00 | 427 | 7,261 | 321,802 | 321.4 K to 321.8 K (+0.13 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.35 | 135 | 2,072 | 321,375 | 321.2 K to 321.4 K (+0.04 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.53 | 7,228 | 112,244 | 321,240 | 314 K to 321.2 K (+2.30 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 15.45 | 7,787 | 120,334 | 314,012 | 306.2 K to 314 K (+2.54 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.98 | 52 | 779 | 306,225 | 306.2 K to 306.2 K (+0.02 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.98 | 95 | 1,423 | 306,173 | 306.1 K to 306.2 K (+0.03 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.79 | 2,562 | 37,892 | 306,078 | 303.5 K to 306.1 K (+0.84 %) |
Aug 25 2011 | SGEN | SEATTLE GENETICS I ... | 14159 capital (GP), LLC | Director | Buy | P | 14.60 | 67 | 978 | 303,516 | 303.4 K to 303.5 K (+0.02 %) |
Aug 24 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 9.93 | 1,001 | 9,938 | 149,544 | 148.5 K to 149.5 K (+0.67 %) |
Aug 24 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 9.97 | 3,339 | 33,287 | 148,543 | 145.2 K to 148.5 K (+2.30 %) |
Aug 24 2011 | PCYC | PHARMACYCLICS INC | 14159 capital (GP), LLC | 10% Owner | Buy | P | 10.00 | 86 | 860 | 145,204 | 145.1 K to 145.2 K (+0.06 %) |
Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 17.25 | 1,001 | 17,265 | 132,889 | 133.9 K to 132.9 K (-0.75 %) |
Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 18.04 | 9,678 | 174,580 | 133,890 | 143.6 K to 133.9 K (-6.74 %) |
Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 18.03 | 6,400 | 115,389 | 143,568 | 150 K to 143.6 K (-4.27 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.35 | 35 | 922 | 161,659 | 161.6 K to 161.7 K (+0.02 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.30 | 112 | 2,945 | 161,624 | 161.5 K to 161.6 K (+0.07 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.25 | 1,524 | 40,005 | 161,512 | 160 K to 161.5 K (+0.95 %) |
Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.10 | 273 | 7,125 | 159,988 | 159.7 K to 160 K (+0.17 %) |